Baird lowered the firm’s price target on Molina Healthcare (MOH) to $179 from $373 and keeps a Neutral rating on the shares as part of an update on the managed care and healthcare facilities group. The firm is increasingly cautious on Medicaid and the healthcare exchange.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Cantor downgrades Molina to Neutral on Medicaid uncertainty
- Molina Healthcare Reports Q2 2025 Financial Results
- Molina Healthcare Earnings Call: Mixed Sentiment Amid Growth
- Molina Healthcare downgraded to Neutral from Overweight at Cantor Fitzgerald
- Molina Healthcare price target lowered to $190 from $218 at BofA